Regulatory
New Zealand Medsafe and Natural Health Products: Where EBC-46 Supplements Fit
How blushwood berry extract supplements are classified under New Zealand's Dietary Supplements Regulations and the proposed Therapeutic Products Act framework.
Regulatory
Brazil ANVISA Botanical Medicine Framework: How EBC-46 Supplements Are Classified
A neutral overview of how Brazil's ANVISA classifies botanical products and how EBC-46 / blushwood berry supplements would fit within the country's tiered regulatory pathways.
Regulatory
Health Canada NHPD: How EBC-46 Botanical Supplements Are Classified Under Canadian Natural Health Product Regulations
Examining how Canadian Natural Health Product regulations under Health Canada's NHPD classify blushwood berry extract supplements containing EBC-46.
Regulatory
Mexico COFEPRIS and EBC-46 Botanical Supplements: Classification and Import Pathway
How Mexico's COFEPRIS classifies imported botanical supplements like blushwood berry extract under the suplemento alimenticio framework, and what documentation matters at customs.
Regulatory
India's FSSAI and EBC-46: How the Nutraceutical Framework Treats Botanical Supplements
How India's FSSAI Nutraceutical Regulations classify botanical supplements like blushwood berry extract — and what consumers and importers should expect.
Regulatory
Singapore HSA and EBC-46: How the Health Products Act Treats Botanical Supplements
How Singapore's Health Sciences Authority classifies botanical supplements like blushwood berry extract, the dealer's licence framework, and what cross-border buyers should understand.
Regulatory
Japan's PMDA and the Food with Function Claims Framework for Botanical Supplements
How Japan's PMDA separates pharmaceuticals from functional foods, what the FFC notification pathway means for EBC-46 supplements, and how to read a Japanese-market label.
Regulatory
South Korea MFDS and EBC-46: Health Functional Food Framework for Botanical Supplements
How South Korea's MFDS Health Functional Food framework would classify blushwood berry extract supplements and what documentation Korean regulators expect from manufacturers.
Regulatory
Brazil ANVISA and EBC-46: Botanical Supplement Classification and Import Framework in 2026
How Brazil’s ANVISA classifies botanical supplements containing blushwood berry extract, and what the 2026 import notification and labelling framework means for buyers.
Regulatory
Swiss Swissmedic and EBC-46: Complementary Medicines Licensing for Blushwood Berry in Switzerland
How Switzerland’s Swissmedic regulates complementary and herbal medicines, and where blushwood berry extract products sit within the Swiss supplement framework.
EBC-46
UK MHRA and Botanical Supplements: Where EBC-46 Fits in the UK Regulatory Framework
How the UK MHRA and Food Standards Agency treat EBC-46 supplements: not medicines, regulated as food supplements, with no therapeutic claims permitted.
Regulatory
FDA Enforcement Discretion and Botanical Supplements: How EBC-46 Products Operate Within Established Precedent
How the FDA's consistent enforcement discretion framework applies to botanical supplements like EBC-46, and what established legal precedent means for the category.